HTG MOLECULAR DIAGNOSTICS, INC short interest in 2021
In 2021, HTG MOLECULAR DIAGNOSTICS, INC's disclosed short interest ran from 0.98% of shares outstanding on 15 Mar 2021 to 1.54% on 31 Dec 2021, a change of +0.56 percentage points. The year's high was 5.07% on 15 Jul 2021 and its low 0.98% on 15 Mar 2021, averaging 2.59% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.39 days on 15 Oct 2021. Full history: HTG MOLECULAR DIAGNOSTICS, INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022
2021 in figures
- Start of year
- 0.98% (15 Mar 2021)
- End of year
- 1.54% (31 Dec 2021)
- Change
- +0.56 pp
- High
- 5.07% (15 Jul 2021)
- Low
- 0.98% (15 Mar 2021)
- Average
- 2.59%
- Highest days to cover
- 7.39 (15 Oct 2021)
- SEC filings marked
- 11
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Mar 2021 | 0.98% | 1.00 | results (8-K), results (8-K) |
| 31 Mar 2021 | 1.54% | 1.54 | 10-K filed, results (8-K) |
| 15 Apr 2021 | 2.28% | 1.00 | results (8-K) |
| 30 Apr 2021 | 2.86% | 4.33 | |
| 14 May 2021 | 2.70% | 1.99 | 10-Q filed, results (8-K) |
| 28 May 2021 | 3.62% | 4.46 | |
| 15 Jun 2021 | 4.15% | 1.67 | |
| 30 Jun 2021 | 4.66% | 3.20 | |
| 15 Jul 2021 | 5.07% | 2.87 | |
| 30 Jul 2021 | 4.72% | 3.67 | |
| 13 Aug 2021 | 3.59% | 4.20 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 2.32% | 2.54 | |
| 15 Sep 2021 | 2.33% | 4.67 | |
| 30 Sep 2021 | 1.70% | 5.40 | |
| 15 Oct 2021 | 2.05% | 7.39 | |
| 29 Oct 2021 | 1.80% | 7.16 | |
| 15 Nov 2021 | 1.58% | 4.55 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 1.10% | 1.62 | |
| 15 Dec 2021 | 1.20% | 1.28 | |
| 31 Dec 2021 | 1.54% | 1.19 |
See also: HTG MOLECULAR DIAGNOSTICS, INC's full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.